APLS - Apellis Pharmaceuticals GAAP EPS of -$0.54 misses by $0.09 revenue of $172.3M beats by $8.04M
2024-05-07 07:16:06 ET
More on Apellis Pharmaceuticals
- Apellis Pharmaceuticals, Inc. (APLS) Q4 and Full Year 2023 Earnings Call Transcript
- Apellis Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Apellis Pharmaceuticals: Eye Disease Drug Syfovre On Comeback Trail - But Risks Remain
- Apellis Pharmaceuticals Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Apellis Pharmaceuticals